Hall, Jane

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Munro, A. P. S., Feng, S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 175

Breaking up is hard to do: why disinvestment in medical technology is harder than investment

Haas, M., Hall, J., Viney, R., & Gallego, G. (2012) · Australian Health Review

Health Systems, Economic Evaluations, Quality of LifeHealthcare cost, quality, practices

Cited by 66

Can short-term memory be trained?

Norris, D. G., Hall, J., & Gathercole, S. E. (2019) · Memory & Cognition

Cognitive Abilities and TestingCognitive Functions and Memory

Cited by 31